Southeast Retina Center, Georgia
Quick facts
Marketed products
- Alflibercept · Other
- Rescue Intravitreal Aflibercept Injection · Ophthalmology
Aflibercept is a recombinant fusion protein that binds vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) to inhibit abnormal blood vessel growth in the retina.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Southeast Retina Center, Georgia portfolio CI brief
- Southeast Retina Center, Georgia pipeline updates RSS
Frequently asked questions about Southeast Retina Center, Georgia
What are Southeast Retina Center, Georgia's marketed drugs?
Top marketed products include Alflibercept, Rescue Intravitreal Aflibercept Injection.
Related
- Alflibercept · Other
- Rescue Intravitreal Aflibercept Injection · Ophthalmology
- Sector hub: All tracked pharma companies